insights_auto
Why is MBIO down 2.52%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.39
arrow_downward
-2.52%(-0.010) 1D
Oct 12, 12:55:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.41
High
$0.44
Low
$0.39
Mkt. cap
3.01M
Avg. vol.
31.29K
Volume
31.08K
52-wk high
$1.69
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.41
High
$0.44
Low
$0.39
Mkt. cap
3.01M
Avg. vol.
31.29K
Volume
31.08K
52-wk high
$1.69
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 week ago
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Revenue Warning Signal
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com